Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-11-29

Clinical Trial Update: Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial on improving migraine outcomes in patients presenting to the Emergency Department has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Migraine | Phase 4 | Status: WITHDRAWN